Study Human Digital Support Transitional Care

Aging Clinical Trial

— SUNH-ST  

Official title:

Contribution of a Digital Tool Combined With Supportive Human Coordination for Transitional Care of Patients in Unscheduled Hospitalisation in Geriatric Short-stay Care

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06354166
• Other study ID #: 2023-A02745-40
• Status: Not yet recruiting
• Phase: N/A
• Start date: April 2024
• Est. completion date: March 2025

Study information

• Verified date: April 2024
• Source: Divoluci
• Contact: Wassim GANA
• Phone: 247474747
• Email: w.gana[@]chu-tours.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to compare the effectiveness of Divomed in organising complex hospital discharges with a conventional organisation. Effectiveness will be assessed by reducing the length of stay of patients in geriatric short-stay care.

Description:

This is an interventional, randomised (ratio 1:1), single-centre, open-label study evaluating Divomed, a digital tool combined with human coordination, to speed up the discharge of people aged over 75 from unscheduled short-stay geriatric hospital admissions to their homes. The study population will be patients aged 75 or over, admitted for short term unscheduled geriatric hospitalisation and eligible for discharge home.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 150
• Est. completion date: March 2025
• Est. primary completion date: March 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 75 Years and older

Eligibility

Inclusion Criteria:

• Age = 75 years ;
• Unplanned hospitalisation from emergency, transfers from other inpatient departments or outpatient medicine;
• Patient eligible for short-stay geriatric hospitalisation estimated to last at least 10 days;
• Patient eligible for a return home;
• Patients who have been informed and have signed an informed consent form. If necessary (for cognitive or other reasons), the information must be given to a third party, i.e. the patient's legal representative or trusted person (independent of the investigator and the sponsor), who may be asked to sign or co-sign the informed consent form (depending on the patient's vulnerability).

Exclusion Criteria:

• Patients scheduled for transfusion, iron infusion or colonoscopy;
• Patients in palliative care;
• Geographical area other than department 37;
• Planned discharge from hospital to a residential establishment for dependent elderly people or to follow-up and rehabilitation care or long-term care units;
• Patient or deprived of liberty by judicial or administrative decision ;
• Patient participating in or being excluded from another clinical trial;
• Patients not covered by a social security scheme.

Related Conditions & MeSH terms

• Aging

Intervention

Procedure:
• Unscheduled hospital admissions
Unscheduled short-stay geriatric hospitalisations of people aged over 75 to their homes

Locations

Country	Name	City	State
France	CHRU de Tours - Hôpital Bretonneau	Tours

Sponsors (1)

Lead Sponsor	Collaborator
Divoluci

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	length of stay	The effectiveness of Divomed in organising complex hospital discharges will be assessed at discharge by comparing lengths of stay in the 2 groups.	1 month